Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Leishmaniasis Vaccines
New leishmaniasis vaccines research from World Health Organization discussed
February 4th, 2009
Research findings, 'First generation leishmaniasis vaccines: a review of field efficacy trials,' are discussed in a new report. According to recent research published in the journal Vaccine, "First generation candidate vaccines against leishmaniasis, prepared using inactivated whole parasites as their main ingredient, were considered as promising because of their relative ease of production and low cost. These vaccines have been the subject of many investigations over several decades and are the only leishmaniasis vaccine candidates which have undergone phase 3 clinical trial evaluation." "Although the studies demonstrated the safety of the vaccines and several...
Source: Vaccine Weekly (2009-02-04)
|
